Lotus Ventures Inc. (CSE:J, FRA:LV9, OTC:LTTSF) (the “Company” or “Lotus”) has successfully harvested its initial batch of cannabis comprised of high-quality and award-winning strains. Naturally, the harvest, drying, and curing stages are vital to a producer’s final product, and our team feels confident with their experience in each stage.

Subsequent to drying and trimming the cannabis for two-to-three weeks, Lotus will then send a representative sample to a third-party laboratory for microbiological testing. Once the Company has received a Confirmation of Analysis (COA) confirming the product conforms to Health Canada’s testing requirements, bulk shipments are expected to be delivered to its streaming partner Auxly Cannabis Group Inc. immediately.

New Investor Presentation

With the recent news regarding the vaping industry, Lotus believes it has taken the right approach to focus on the cultivation aspect of the business before rushing into the next wave of value-added products. As we have seen in mature American markets, dried cannabis flower continues to command higher market share, and the Company does not see this trend changing in the near term as more Canadian flower consumers transition into licensed retail channels.

To read more about these trends and how we expect to reach our business objectives, download our new investor presentation below.

Link: https://gallery.mailchimp.com/443ef150b49b3f9ae9280d318/files/b59914c5-2a15-4c0d-b893-b95be85bc872/LotusInvestorDeck_compressed.pdf


Lotus Ventures Inc.

“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.

Lotus Ventures Inc. (CSE: J) is an Okanagan-based licensed producer focused on growing exceptional cannabis products for the wholesale and recreational market in Canada. Lotus operates an innovative 22,500 square foot growing facility with access to unique proven strains and an entirely handcrafted production process created by one of the regions most experienced growing teams.

For Further Information:

Dale McClanaghan, CEO: dalemcclanaghan@gmail.com 604-644-9844

Daniel McRobert, Investor Relations: investors@lotuscannabis.ca 604-842-4625

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation.



Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less